Jacob Hughes
Stock Analyst at Wells Fargo
(1.41)
# 2,695
Out of 4,667 analysts
31
Total ratings
57.14%
Success rate
7.84%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jacob Hughes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMPH Amphastar Pharmaceuticals | Maintains: Equal-Weight | $40 → $44 | $44.09 | -0.20% | 5 | May 17, 2023 | |
| PRGO Perrigo Company | Upgrades: Overweight | $54 | $27.15 | +98.90% | 1 | Sep 6, 2022 | |
| RVNC Revance Therapeutics | Maintains: Equal-Weight | $17 → $24 | $3.80 | +531.58% | 4 | Aug 25, 2022 | |
| IRWD Ironwood Pharmaceuticals | Maintains: Equal-Weight | $12 → $13 | $3.52 | +269.32% | 3 | Aug 16, 2022 | |
| MDWD MediWound | Maintains: Overweight | $49 → $56 | $16.78 | +233.73% | 1 | May 18, 2022 | |
| EBS Emergent BioSolutions | Maintains: Equal-Weight | $46 → $38 | $8.88 | +327.93% | 3 | May 4, 2022 | |
| TEVA Teva Pharmaceutical | Maintains: Equal-Weight | $12 → $11 | $17.03 | -35.41% | 11 | Jul 29, 2021 | |
| BHC Bausch Health Companies | Maintains: Equal-Weight | $18 → $17 | $8.19 | +107.57% | 3 | Oct 28, 2020 |
Amphastar Pharmaceuticals
May 17, 2023
Maintains: Equal-Weight
Price Target: $40 → $44
Current: $44.09
Upside: -0.20%
Perrigo Company
Sep 6, 2022
Upgrades: Overweight
Price Target: $54
Current: $27.15
Upside: +98.90%
Revance Therapeutics
Aug 25, 2022
Maintains: Equal-Weight
Price Target: $17 → $24
Current: $3.80
Upside: +531.58%
Ironwood Pharmaceuticals
Aug 16, 2022
Maintains: Equal-Weight
Price Target: $12 → $13
Current: $3.52
Upside: +269.32%
MediWound
May 18, 2022
Maintains: Overweight
Price Target: $49 → $56
Current: $16.78
Upside: +233.73%
Emergent BioSolutions
May 4, 2022
Maintains: Equal-Weight
Price Target: $46 → $38
Current: $8.88
Upside: +327.93%
Teva Pharmaceutical
Jul 29, 2021
Maintains: Equal-Weight
Price Target: $12 → $11
Current: $17.03
Upside: -35.41%
Bausch Health Companies
Oct 28, 2020
Maintains: Equal-Weight
Price Target: $18 → $17
Current: $8.19
Upside: +107.57%